King of Hearts
510(k) K880626
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK880626 | Date11 Apr 1988 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DXH
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.2920
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 23 Sep 2026
The device is a transmitter and receiver for electrocardiograph telephone systems, classified under the cardiovascular medical specialty. It is a substantially equivalent device cleared through the traditional 510(k) pathway.
Manufactured by Instromedix, Inc., the device received FDA 510(k) clearance under K880626 on April 11, 1988, following submission on February 16, 1988. It is associated with product code DXH and regulation number 870.2920, and is registered under multiple facility establishment identifiers.
Other devices from Instromedix, Inc.
Questions
AI-generated answers, 23 Sep 2026
What is the KING OF HEARTS device used for?
The KING OF HEARTS is a transmitter and receiver designed for electrocardiograph telephone systems, enabling remote transmission of ECG signals over telephone lines for cardiovascular monitoring and diagnostic support.
Who manufactures the KING OF HEARTS device and when was it cleared?
The KING OF HEARTS is manufactured by Instromedix, Inc. and received FDA 510(k) clearance under submission K880626 on April 11, 1988, following an initial submission on February 16, 1988.
What regulatory pathway and classification apply to the KING OF HEARTS?
The KING OF HEARTS was cleared through the traditional 510(k) pathway as a substantially equivalent device, classified as a Class II medical device under product code DXH and regulation number 870.2920 in the cardiovascular specialty.